Withdrawal from addictive drugs can be reduced by administering placebo deceptively, but in the clinic it is unethical to deceive the patient. Open-label placebo effects have been observed across a range of psychophysiological phenomena, and may also apply to drug withdrawal.
Method:
24-hour abstinent heavy coffee drinkers (N = 61) rated their caffeine withdrawal symptoms before being allocated to one of three groups. The Deceptive group was given decaffeinated coffee (decaf) and told it was caffeinated, the Open-Label group given decaf and told it was decaf and the Control group given water and told it was water. After 45 min, caffeine withdrawal was measured again. All participants rated their expectancies of withdrawal reduction from caffeinated coffee, decaf and water prior to being randomised and the end of the study.
Results:
There was a significant 9.5-point reduction in caffeine withdrawal in the Open-Label group (95% confidence interval (CI): 4.7, 14.3; p = 0.002), which was 8.6 points less than the Deceptive group (95%CI: 0.4, 16.8; p = 0.014) but 8.9 points greater than the Control group (95%CI: 0.6, 17.2; p = 0.012). Pre-randomisation, participants expected caffeinated coffee to reduce their withdrawal symptoms the most, followed by water and decaf, Pre-randomisation expectancy of withdrawal was only associated with amount of withdrawal reduction in the Deceptive group.
Conclusion:
It appears as if open-label placebo caffeine (i.e. decaf) can reduce caffeine withdrawal symptoms, even when people do not hold a conscious expectancy it will do so. There may be ways to integrate open-label placebo procedures into clinical interventions for drug dependence without violating informed consent.
AllsopDJCopelandJNorbergMM, et al. (2012) Quantifying the clinical significance of cannabis withdrawal. PloS One7: e44864.
2.
AtlasLYWielgoszJWhittingtonRA, et al. (2014) Specifying the non-specific factors underlying opioid analgesia: Expectancy, attention, and affect. Psychopharmacology231: 813–823.
3.
BakerTBPiperMEMcCarthyDE, et al. (2004) Addiction motivation reformulated: An affective processing model of negative reinforcement. Psychol Rev111: 33–51.
4.
BarnesKYuAJosupeitJ, et al. (2019) Deceptive but not open label placebos attenuate motion-induced nausea. J Psychosom Res125: 109808.
Bowden-JonesHMcPhillipsMRogersR, et al. (2005) Risk-taking on tests sensitive to ventromedial prefrontal cortex dysfunction predicts early relapse in alcohol dependency: A pilot study. J Neuropsychiatry Clin Neurosci17: 417–420.
8.
BretzFHothornTWestfallP (2016) Multiple comparisons using R. CRC Press.
9.
ButlerCSteptoeA (1986) Placebo responses: An experimental study of psychophysiological processes in asthmatic volunteers. Br J Clin Psychol25: 173–183.
10.
CapellHLe BlancA (1981) Tolerance and physical dependence: Do they play a role in alcohol and drug self-adminstration?Res Adv Alcohol Drug Prob6: 159–196.
11.
CarvalhoCCaetanoJMCunhaL, et al. (2016) Open-label placebo treatment in chronic low back pain: A randomized controlled trial. Pain (Amsterdam)157: 2766–2772.
12.
ColagiuriBMorleyKBoakesR, et al. (2009) Expectancy in double-blind placebo-controlled trials: An example from alcohol dependence. Psychother Psychosom78: 167–171.
13.
CollocaLHowickJ (2018) Placebos without deception: Outcomes, mechanisms, and ethics. Int Rev Neurobiol138: 219–240.
14.
CollocaLMillerFG (2011) How placebo responses are formed: A learning perspective. Philos Trans R Soc B: Biolog Sci366: 1859–1869.
15.
CropseyKLSchiavonSHendricksPS, et al. (2017) Mixed-amphetamine salts expectancies among college students: Is stimulant induced cognitive enhancement a placebo effect?Drug Alcohol Depend178: 302–309.
16.
DarredeauCBarrettSP (2010) The role of nicotine content information in smokers’ subjective responses to nicotine and placebo inhalers. Hum Psychopharmacol: Clin Exp25: 577–581.
17.
ErnstEReschK (1995) Concept of true and perceived placebo effects. BMJ: Br Med J311: 551.
18.
FrancisDANelsonJAA (1984) Effect of patient recognition of tranquilizers on their use in alcohol detoxification. Am J Hosp Pharm41: 488.
19.
FriehsTRiefWGlombiewskiJA, et al. (2022) Deceptive and non-deceptive placebos to reduce sadness: A five-armed experimental study. J Affect Disord Rep9: 100349.
20.
GossopMStewartDMarsdenJ (2006) Effectiveness of drug and alcohol counselling during methadone treatment: Content, frequency, and duration of counselling and association with substance use outcomes. Addiction101: 404–412.
21.
GottliebAMKillenJDMarlattGA, et al. (1987) Psychological and pharmacological influences in cigarette smoking withdrawal: Effects of nicotine gum and expectancy on smoking withdrawal symptoms and relapse. J Consult Clin Psychol55: 606–608.
22.
HaasJWRiefWGlombiewskiJA, et al. (2020) Expectation-induced placebo effect on acute sadness in women with major depression: An experimental investigation. J Affect Disord274: 920–928.
23.
HaasJWWinklerARhekerJ, et al. (2022) No open-label placebo effect in insomnia? Lessons learned from an experimental trial. J Psychosom Res158: 110923.
24.
JulianoLMGriffithsRR (2004) A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology176: 1–29.
25.
JulianoLMHuntleyEDHarrellPT, et al. (2012) Development of the caffeine withdrawal symptom questionnaire: Caffeine withdrawal symptoms cluster into 7 factors. Drug Alcohol Depend124: 229–234.
26.
JulianoLMKardelPGHarrellPT, et al. (2019) Investigating the role of expectancy in caffeine withdrawal using the balanced placebo design. Hum Psychopharmacol34: e2692-n/a.
27.
Kam-HansenSJakubowskiMKelleyJM, et al. (2014) Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Trans Med6: 218ra215–218ra215.
28.
KaptchukTJFriedlanderEKelleyJM, et al. (2010) Placebos without deception: A randomized controlled trial in irritable bowel syndrome. PloS One5: e15591.
29.
KelleyJMKaptchukTJCusinC, et al. (2012) Open-label placebo for major depressive disorder: A pilot randomized controlled trial. Psychother Psychosom81: 312–314.
30.
KillenJDFortmannSPKraemerHC, et al. (1992) Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. J Consult Clin Psychol60: 797–801.
31.
KirschIKongJSadlerP, et al. (2014) Expectancy and conditioning in placebo analgesia: Separate or connected processes?Psychol Conscious (Washington, D.C.)1: 51–59.
32.
KirschIRosadinoMJ (1993) Do double-blind studies with informed consent yield externally valid results? An empirical test. Psychopharmacology110: 437–442.
33.
KirschIWeixelLJ (1988) Double-blind versus deceptive administration of a placebo. Behav Neurosci102: 319–323.
34.
KostenTRO’ConnorPG (2003) Management of drug and alcohol withdrawal. N Engl J Med348: 1786–1795.
35.
LappWMCollinsRLZywiakWH, et al. (1994) Psychopharmacological effects of alcohol on time perception: The extended balanced placebo design. J Stud Alcohol55: 96–112.
36.
LemboAKelleyJMNeeJ, et al. (2021) Open-label placebo vs double-blind placebo for irritable bowel syndrome: A randomized clinical trial. Pain (Amsterdam)162: 2428–2435.
LocherCFrey NascimentoAKirschI, et al. (2017) Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. Pain (Amsterdam)158: 2320–2328.
39.
LongoDLDuffeyPLKoppWC, et al. (1999) Conditioned immune response to interferon-γ in humans. Clin Immunol90: 173–181.
40.
MarlattGARohsenowDJ (1980) Cognitive processes in alcohol use: Expectancy and the balanced placebo design. Adv Subst Abus: Behav Biol Res1: 159–199.
41.
McCarthyDEPiaseckiTMFioreMC, et al. (2006) Life before and after quitting smoking: An electronic diary study. J Abnorm Psychol115: 454.
42.
MetrikJKahlerCWReynoldsB, et al. (2012) Balanced placebo design with marijuana: Pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology223: 489–499.
43.
MetrikJRohsenowDJMontiPM, et al. (2009) Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol17: 217.
MillsLBoakesRAColagiuriB (2018) The effect of dose expectancies on caffeine withdrawal symptoms during tapered dose reduction. J Psychopharmacol33: 994–1002.
46.
MillsLDar-NimrodIColagiuriB (2017) Effect of genetic information and information about caffeine content on caffeine withdrawal symptoms. Sci Rep7: 1.
47.
MitchellSHLaurentCLDe WitH (1996) Interaction of expectancy and the pharmacological effects of d-amphetamine: Subjective effects and self-administration. Psychopharmacology125: 371–378.
48.
NeukirchNColagiuriB (2015) The placebo effect, sleep difficulty, and side effects: A balanced placebo model. J Behav Med38: 273–283.
49.
PiaseckiTM (2006) Relapse to smoking. Clin Psychol Rev26: 196–215.
50.
PiaseckiTMFioreMCBakerTB (1998) Profiles in discouragement: Two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol107: 238.
51.
PinheiroJBatesDDebRoyS, et al. (2016) Nlme: Linear and nonlinear mixed effects models. R package version 3.1-128.
52.
PiperMESchlamTRCookJW, et al. (2011) Tobacco withdrawal components and their relations with cessation success. Psychopharmacology216: 569–578.
53.
PolloAAmanzioMArslanianA, et al. (2001) Response expectancies in placebo analgesia and their clinical relevance. PAIN93: 77–84.
54.
PolloATorreELopianoL, et al. (2002) Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport13: 1383–1386.
55.
PriceDDFinnissDGBenedettiF (2008) A comprehensive review of the placebo effect: Recent advances and current thought. Ann Rev Psychol59: 565–590.
56.
R Core Team (2016) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. https://www.R-project.org/
57.
RubinGJSmithAP (1999) Caffeine withdrawal and headaches. Nutr Neurosci2: 123–126.
58.
SandlerADBodfishJW (2008) Open-label use of placebos in the treatment of ADHD: A pilot study. Child Care Health Dev34: 104–110.
59.
SandlerADGlesneCEBodfishJW (2010) Conditioned placebo dose reduction: A new treatment in attention-deficit hyperactivity disorder?J Dev Behav Pediatr31: 369–375.
60.
SchaeferMSahinTBerstecherB (2018) Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis. PloS One13: e0192758.
61.
SchaferSMCollocaLWagerTD (2015) Conditioned placebo analgesia pe rsists when subjects know they are receiving a placebo. J Pain16: 412–420.
62.
SenayECDorusWThorntonW (1977) Withdrawal from methadone maintenance: Rate of withdrawal and expectation. Arch Gen Psychiatry34: 361–367.
63.
ShephardABarrettSP (2022) The impacts of caffeine administration, expectancies, and related stimuli on coffee craving, withdrawal, and self-administration. J Psychopharmacol36: 378–386.
64.
SmitHRogersP (2007) Effects of caffeine on mood. Boca Raton: CRC Press.
65.
SmithAP (1996) Caffeine dependence: An alternative view. Nat Med2: 494–494.
66.
StevensLGoudriaanAEVerdejo-GarciaA, et al. (2015) Impulsive choice predicts short-term relapse in substance-dependent individuals attending an in-patient detoxification programme. Psychol Med45: 2083–2093.
67.
StrongDRLeventhalAMEvattDP, et al. (2011) Positive reactions to tobacco predict relapse after cessation. J Abnorm Psychol120: 999.
68.
SuetsugiMMizukiYYamamotoK, et al. (2007) The effect of placebo administration on the first-night effect in healthy young volunteers. Prog Neuropsychopharmacol Biol Psychiatry31: 839–847.
69.
SukhanovaAMPonomarevaNIPerovaIB, et al. (2021) Determination of therapeutic substance sibutramine using physicochemical methods in the composition of multicomponent biologically active food supplements. Pharm Chem J54: 1173–1177.
70.
VaillantGE (1988) What can long-term follow-up teach us about relapse and prevention of relapse in addiction?Br J Addict83: 1147–1157.
71.
WestRJHajekPBelcherM (1989) Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med19: 981–985.
72.
WestfallPHYoungSS (1993) Resampling-based multiple testing: Examples and methods for p-value adjustment. Hoboken, NJ: John Wiley & Sons.
73.
WickhamH (2017) Tidyverse: Easily install and load’tidyverse’packages. R package version 1.2.1 1(1).
74.
WigmoreSWHinsonRE (1991) The influence of setting on consumption in the balanced placebo design. Br J Addict86: 205–215.
75.
WiklerA (1948) Recent progress in reaseach on the neurophysiologic basis of morphine addiction. Am J Psychiatry105: 329–338.
76.
WiklerA (1973) Dynamics of drug dependence: Implications of a conditioning theory for research and treatment. Arch Gen Psychiatry28: 611.
77.
YeungSTAColagiuriBLovibondPF, et al. (2014) Partial reinforcement, extinction, and placebo analgesia. PAIN®155: 1110–1117.
78.
ZhouESHallKTMichaudAL, et al. (2018) Open-label placebo reduces fatigue in cancer survivors: A randomized trial. Support Care Cancer27: 2179–2187.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
